Well-differentiated NET G3 and poorly differentiated NEC, both with high proliferation rates of more than 20% Ki67-positive cells, separated from NET G1 (less than 3% Ki67-positive tumor cells) and NET G2 (3–20% Ki67-positive tumor cells; Fig. 3B). The gene discussed is MKI67; the disease is neuroendocrine carcinoma.